Stock 1733 APEX BIOTECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Apex Biotechnology Corp.

Equities

1733

TW0001733004

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
34.05 TWD +0.89% Intraday chart for Apex Biotechnology Corp. +1.79% -15.51%
Mar. 14 Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Apex Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,961 2,834 2,361 2,599 2,554 4,028
Enterprise Value (EV) 1 2,999 2,642 2,052 2,258 2,337 3,737
P/E ratio 33.1 x 27.2 x 27.2 x 13.5 x 14.1 x 35 x
Yield 2.86% 3.88% 4.61% 5% 5.48% 2.73%
Capitalization / Revenue 1.45 x 1.29 x 1.18 x 1.22 x 1.14 x 2.4 x
EV / Revenue 1.47 x 1.2 x 1.02 x 1.06 x 1.04 x 2.23 x
EV / EBITDA 9.12 x 8.61 x 10.3 x 7.74 x 8.99 x 18.1 x
EV / FCF -51 x 5.83 x 10.3 x 41 x -29.9 x 22.7 x
FCF Yield -1.96% 17.2% 9.71% 2.44% -3.35% 4.4%
Price to Book 1.8 x 1.69 x 1.43 x 1.48 x 1.41 x 2.24 x
Nbr of stocks (in thousands) 99,690 99,950 99,611 99,950 99,950 99,950
Reference price 2 29.70 28.35 23.70 26.00 25.55 40.30
Announcement Date 3/27/19 3/25/20 3/29/21 3/22/22 3/13/23 3/14/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,044 2,199 2,005 2,132 2,244 1,677
EBITDA 1 328.7 307 199.8 291.6 260.1 206.5
EBIT 1 227.4 203.3 103.3 204.9 176.6 141.7
Operating Margin 11.12% 9.24% 5.15% 9.61% 7.87% 8.45%
Earnings before Tax (EBT) 1 161.3 162.9 110.6 184.9 199.6 141
Net income 1 95.12 113.9 94.8 202.2 181.8 115.8
Net margin 4.65% 5.18% 4.73% 9.49% 8.1% 6.91%
EPS 2 0.8976 1.042 0.8729 1.929 1.810 1.150
Free Cash Flow 1 -58.84 453.6 199.1 55.06 -78.18 164.4
FCF margin -2.88% 20.63% 9.93% 2.58% -3.48% 9.81%
FCF Conversion (EBITDA) - 147.73% 99.64% 18.88% - 79.6%
FCF Conversion (Net income) - 398.38% 210.05% 27.23% - 141.98%
Dividend per Share 2 0.8500 1.100 1.094 1.300 1.400 1.100
Announcement Date 3/27/19 3/25/20 3/29/21 3/22/22 3/13/23 3/14/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3
Net sales 1 - 608.1 605.5
EBITDA - - -
EBIT 1 - 33.54 52.6
Operating Margin - 5.51% 8.69%
Earnings before Tax (EBT) 1 - 27.59 70.86
Net income 1 45.59 29.06 64
Net margin - 4.78% 10.57%
EPS 2 0.4500 0.2900 0.6400
Dividend per Share - - -
Announcement Date 5/11/22 8/10/22 11/9/22
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 38.5 - - - - -
Net Cash position 1 - 191 309 341 217 291
Leverage (Debt/EBITDA) 0.1172 x - - - - -
Free Cash Flow 1 -58.8 454 199 55.1 -78.2 164
ROE (net income / shareholders' equity) 5.66% 6.8% 5.7% 11.9% 10.2% 6.4%
ROA (Net income/ Total Assets) 5.42% 4.74% 2.36% 4.81% 4.26% 3.68%
Assets 1 1,756 2,402 4,011 4,201 4,271 3,145
Book Value Per Share 2 16.50 16.80 16.60 17.50 18.20 18.00
Cash Flow per Share 2 3.190 6.540 7.920 5.560 3.320 3.820
Capex 1 75.4 55.1 45.3 26.6 36.6 21.9
Capex / Sales 3.69% 2.51% 2.26% 1.25% 1.63% 1.31%
Announcement Date 3/27/19 3/25/20 3/29/21 3/22/22 3/13/23 3/14/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
APEX BIOTECHNOLOGY CORP. Stock Apex Biotechnology Corp.
-15.51% 104M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+72.92% 12.36B
PENUMBRA, INC. Stock Penumbra, Inc.
-19.68% 7.83B
MASIMO CORPORATION Stock Masimo Corporation
+16.20% 7.21B
GETINGE AB Stock Getinge AB
+6.78% 5.97B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+7.49% 5.14B
APT MEDICAL INC. Stock APT Medical Inc.
+23.97% 4.43B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-18.88% 3.9B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-41.54% 2.2B
SKAN GROUP AG Stock SKAN Group AG
+1.24% 2.02B
Medical Equipment
  1. Stock Market
  2. Equities
  3. 1733 Stock
  4. Financials Apex Biotechnology Corp.